losartan has been researched along with Abnormalities, Multiple in 2 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Abnormalities, Multiple: Congenital abnormalities that affect more than one organ or body structure.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lehnhardt, A | 1 |
Lama, A | 1 |
Amann, K | 1 |
Matejas, V | 1 |
Zenker, M | 1 |
Kemper, MJ | 1 |
Lambot, MA | 1 |
Vermeylen, D | 1 |
Noël, JC | 1 |
2 other studies available for losartan and Abnormalities, Multiple
Article | Year |
---|---|
Pierson syndrome in an adolescent girl with nephrotic range proteinuria but a normal GFR.
Topics: Abnormalities, Multiple; Adolescent; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting | 2012 |
Angiotensin-II-receptor inhibitors in pregnancy.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adult; Antihypertensive Agents; Cesarean Secti | 2001 |